Senate Begins Debate on Prescription Drug Legislation
Last
week, the Senate began what has already become a highly contentious
floor debate on prescription drugs. Under consideration is
a bill that would speed generic
drugs to market. During the floor debate, which could
last as long as two weeks, it is expected that numerous amendments
will be offered to the generic drug bill, including legislation
that would provide Medicare beneficiaries with a prescription
drug benefit. Virtually all amendments offered will need a
60-vote super majority for passage. The conventional wisdom
is that no prescription drug proposal currently on the table
can garner the necessary 60 votes, with the possible exception
of the underlying generic drug bill. It is possible that a
Medicare provider payment package will be offered as an amendment,
although details are still sketchy at this time. Rumors are
that Senate Majority Leader Thomas Daschle, D-ND, is considering
offering the House-passed provider
package as an amendment. While the ACC supported the physician
payment language in the House bill, it continues to lobby
Senate lawmakers for a proposal that would provide a more
permanent solution to the Medicare physician payment update
problem. Visit the "Fight
Medicare Fee Cuts" section on the ACC Web site for
updates.
Medical
Liability Crisis Focus of House Committee Hearing
The House Energy and Commerce Health Subcommittee
last week took up the debate on the medical liability crisis
facing the nation. The hearing highlighted the stark contrast
between Republicans' and Democrats' stance on the issue, with
GOP leaders continuing to press for tort reform legislation
while Democrats called for further examination of the causes
of rising liability insurance premiums. Subcommittee Chairman
Michael Bilirakis, R-Fla., stressed that the medical liability
crisis requires action by the federal government and called
the "HEALTH
Act," H.R. 4600, a bill supported by the ACC, a "common
sense solution" to the problem that respects the states'
role as regulators of the insurance industry. Ranking member
Sherrod Brown, D-Ohio, and other Democrats criticized the
presumption being made by Republicans that malpractice litigation
is the cause of high liability premiums. House Democrats are
in the process of drafting legislation that would focus on
insurer, rather than tort reforms. On
Tuesday, July 23, the House Judiciary Committee will mark-up
H.R. 4600.
ACC-Sponsored
"Cardiologist for A Day" Program Achieves Quick
Results
Ft. Wayne Cardiology (Ind.), a private,
21-physician practice, hosted a "Cardiologist for a Day"
program last week. The ACC Indiana Chapter worked with the
national office and the Indiana State Medical Association
to develop this program. The practice invited local legislators
and the CMS Region V Medical Director, Trent Haywood, MD,
and staff to go "on rounds" with attending cardiologists
to provide a first-hand look at a physician practice. The
participants witnessed some common cardiovascular procedures
and some of the cumbersome regulatory and administrative issues
confronting cardiologists on a daily basis. The program is
intended to facilitate constructive dialogue and positive
relationships, and, in fact, Dr. Haywood has already taken
steps to resolve claims processing issues with Adminstar Federal,
the Medicare Carrier in Indiana. "The state legislators
found the program educational and particularly were interested
in the problems with CMS administration and the impact on
their Medicare voters," said Dr. Michael Mirro, ACC Governor
for Indiana.
FDA
Approves Expanded Indication for Guidant ICDsRevised
7/29/02
Based on the findings from the MADIT II trial, the FDA has
approved an expanded indication for Guidant implantable cardioverter
defibrillators (ICDs). The results from MADIT
II were released in March at the ACC Annual Scientific
Session and simultaneously published in the New England
Journal of Medicine. Guidant ICDs now have approved labeling
for use in patients who have had a previous myocardial infarction
and have an ejection fraction less than or equal to 30 percent.
In MADIT II, use of ICDs in this patient population reduced
total mortality by 31 percent compared to those in the medical
therapy group. More information on the approval is available
on the FDA
Web site.
ACC
Calls on CMS to Provide Payment Data on Prothrombin Time Testing
After four years of ACC effort, the CMS announced last September
that it would provide coverage for home prothrombin time testing
(PST). While the ACC and other interested parties had advocated
that such coverage be provided through a durable medical equipment
(DME) benefit to facilitate appropriate payment, the CMS announced
in May 2002 that home PST would instead be payable through
the physician fee schedule (see Program
Memorandum AB-02-064). Although the ACC was successful
in achieving payment for physician oversight, the payment
rate is so low that patient access to this new benefit is
in question. The College has asked the CMS to provide data
on how it arrived at a payment rate and to monitor this benefit
to make sure it is workable. In the meantime, the ACC has
urged that physicians not be required to act like DME suppliers
and should be reimbursed for the services that they and their
staff provide in the office for the treatment of patients
needing PST.
ACC
Calls for Congress to Grant FDA Authority to Regulate Tobacco
Products
The ACC has joined
with numerous other physician and public health organizations
in an advertising campaign calling for the regulation of tobacco
products by the Food and Drug Administration (FDA). The ACC
supports the "Youth Smoking Prevention and Public Health
Protection Act," S. 2626, introduced by Sens. Edward
Kennedy, D-Mass., Richard Durbin, D-Ill., and Mike DeWine,
R-Ohio, which would give the FDA broad authority over tobacco
products, from restricting advertising aimed at children to
requiring changes to the tobacco products themselves. In March
2000, the Supreme Court ruled that current law does not allow
the FDA to regulate tobacco products.
Despite
Budget Crunch, Massachusetts Legislators Increase Funding
for Provider Oversight
Despite a budget shortfall
that has forced state legislators to make significant cuts
in many state programs, Massachusetts budget negotiators have
increased funding for state oversight of health care providers
by $1 million. According to a Boston Globe report,
in addition to the increased funding, the budget legislation
would shift the boards that oversee physicians, nurses, and
other health care providers from the Office of Consumer Affairs
to the Department of Health. The budget is expected to be
approved by the full state legislature. While funding was
increased for the oversight of providers, a $70 million budget
cut will mean 50,000 people will no longer be eligible for
MassHealth Basic, the state Medicaid program, the Boston
Herald reported.
State
Governors Concerned About Skyrocketing Health Costs
The
National Governor's Association (NGA) met last week to discuss
the current status of the faltering economy and ways to reduce
escalating state health care costs. "Last year was pretty
trying for the nation's governors," said Michigan governor
and NGA Chairman John Engler, R. "We've had to battle
declining tax revenues
and at the same time there's
been an explosion in health care costs." According to
an Associated Press report, the governors' general consensus
was to promote policies that would increase the affordability
and availability of prescription drugs, and to weather the
current economic downturn without making drastic cuts to education
and other social services.
Advocacy
Weekly is a product of the Advocacy Division of the American
College of Cardiology. Questions or comments regarding this
publication should be directed to the Advocacy Division
at 800-435-9203 or to advocacydiv@acc.org.
|